Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Change in Cash (2016 - 2017)

Historic Change in Cash for Tenax Therapeutics (TENX) over the last 8 years, with Q4 2017 value amounting to -$159073.0.

  • Tenax Therapeutics' Change in Cash fell 10171.53% to -$159073.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$8.4 million, marking a year-over-year decrease of 23244.64%. This contributed to the annual value of $85.1 million for FY2024, which is 100927.23% up from last year.
  • As of Q4 2017, Tenax Therapeutics' Change in Cash stood at -$159073.0, which was down 10171.53% from -$469803.0 recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Change in Cash ranged from a high of $9.3 million in Q4 2016 and a low of -$36.4 million during Q3 2014
  • For the 5-year period, Tenax Therapeutics' Change in Cash averaged around -$2.4 million, with its median value being -$837838.0 (2016).
  • Data for Tenax Therapeutics' Change in Cash shows a peak YoY increase of 66490.99% (in 2014) and a maximum YoY decrease of 120541.88% (in 2014) over the last 5 years.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Change in Cash stood at $2.5 million in 2013, then crashed by 398.93% to -$7.6 million in 2014, then soared by 43.75% to -$4.3 million in 2015, then soared by 316.9% to $9.3 million in 2016, then crashed by 101.72% to -$159073.0 in 2017.
  • Its Change in Cash stands at -$159073.0 for Q4 2017, versus -$469803.0 for Q3 2017 and -$4.8 million for Q2 2017.